ALEMBIC PHARMACEUTICALS
Back to Cashflow Statement
|
ALEMBIC PHARMACEUTICALS Last 5 Year Cash Flow from Financing Activities History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Cash Flow from Financing Activities | ₹-164 Cr | ₹444 Cr | ₹-438 Cr | ₹-262 Cr | ₹-217 Cr |
What is the latest Cash Flow from Financing Activities ratio of ALEMBIC PHARMACEUTICALS ?
| Year | Cash Flow from Financing Activities |
|---|---|
| Mar2026 | ₹-164 Cr |
| Mar2025 | ₹444 Cr |
| Mar2024 | ₹-438 Cr |
| Mar2023 | ₹-262 Cr |
| Mar2022 | ₹-217 Cr |
How is Cash Flow from Financing Activities of ALEMBIC PHARMACEUTICALS Trending?
| Years | Cash Flow from Financing Activities | % Change | |
|---|---|---|---|
| Mar2026 | ₹-164 Cr | Negative | |
| Mar2025 | ₹444 Cr | Positive | |
| Mar2024 | ₹-438 Cr | Negative | |
| Mar2023 | ₹-262 Cr | Negative | |
| Mar2022 | ₹-217 Cr | - | |
Compare Cash Flow from Financing Activities of peers of ALEMBIC PHARMACEUTICALS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| ALEMBIC PHARMACEUTICALS | ₹16,540.9 Cr | 4.1% | 15.1% | -17.9% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹467,870.0 Cr | 0.7% | 8.1% | 16% | Stock Analytics | |
| DIVIS LABORATORIES | ₹194,316.0 Cr | 7% | 10.2% | 3.7% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹169,316.0 Cr | 2.5% | 11.3% | 49.6% | Stock Analytics | |
| CIPLA | ₹115,477.0 Cr | -0.3% | 4.1% | -3.3% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹102,156.0 Cr | -3.2% | -3.9% | -3% | Stock Analytics | |
ALEMBIC PHARMACEUTICALS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| ALEMBIC PHARMACEUTICALS | 4.1% |
15.1% |
-17.9% |
| SENSEX | 0.6% |
1.2% |
-7.8% |
You may also like the below Video Courses